CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 33 filers reported holding CARDIOME PHARMA CORP in Q3 2016. The put-call ratio across all filers is 14.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $118,000 | +47.5% | 51,200 | -0.4% | 0.00% | – |
Q4 2017 | $80,000 | -27.3% | 51,400 | 0.0% | 0.00% | – |
Q3 2017 | $110,000 | -52.6% | 51,400 | 0.0% | 0.00% | – |
Q2 2017 | $232,000 | +45.0% | 51,400 | -3.0% | 0.00% | – |
Q1 2017 | $160,000 | +9.6% | 53,000 | 0.0% | 0.00% | – |
Q4 2016 | $146,000 | -12.0% | 53,000 | 0.0% | 0.00% | – |
Q3 2016 | $166,000 | -8.8% | 53,000 | +49.0% | 0.00% | – |
Q2 2016 | $182,000 | +24.7% | 35,580 | 0.0% | 0.00% | – |
Q1 2016 | $146,000 | -48.2% | 35,580 | +2.1% | 0.00% | – |
Q4 2015 | $282,000 | +13.7% | 34,840 | +18.7% | 0.00% | – |
Q3 2015 | $248,000 | 0.0% | 29,360 | +11.1% | 0.00% | – |
Q2 2015 | $248,000 | +40.9% | 26,420 | +38.6% | 0.00% | – |
Q1 2015 | $176,000 | +57.1% | 19,060 | +57.3% | 0.00% | – |
Q4 2014 | $112,000 | +166.7% | 12,120 | +155.7% | 0.00% | – |
Q3 2014 | $42,000 | – | 4,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,195,692 | $4,953,000 | 2.97% |
Tamarack Advisers, LP | 1,875,000 | $2,906,000 | 1.59% |
CLOUGH CAPITAL PARTNERS L P | 2,667,585 | $4,135,000 | 0.34% |
Rock Springs Capital Management LP | 1,200,000 | $1,860,000 | 0.08% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 4,678,364 | $7,251,000 | 0.06% |
KNOTT DAVID M | 67,978 | $105,000 | 0.04% |
PUTNAM INVESTMENTS LLC | 6,184,266 | $9,586,000 | 0.01% |
AlphaOne Investment Services, LLC | 10,625 | $16,000 | 0.01% |
A.R.T. Advisors, LLC | 34,872 | $54,000 | 0.00% |
Virtu Financial LLC | 11,693 | $18,000 | 0.00% |